4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(thiophen-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(thiophen-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(thiophen-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-0155 |
| Compound Name: | 4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-N-[(thiophen-2-yl)methyl]-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 420.46 |
| Molecular Formula: | C17 H16 N4 O5 S2 |
| Smiles: | Cc1nc(CN2C(COc3ccc(cc23)S(NCc2cccs2)(=O)=O)=O)no1 |
| Stereo: | ACHIRAL |
| logP: | 1.7735 |
| logD: | 1.773 |
| logSw: | -2.7226 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 99.012 |
| InChI Key: | OHTYVNIFCGPJDW-UHFFFAOYSA-N |